Quality of life of patients during antineoplastic therapy: a descriptive study

Abstract

Aim: To evaluate the quality of life of cancer patients using the device for antineoplastic continuous infusion. Method: This is a cross-sectional study conducted with 28 patients in a health insurance company of Fortaleza/CE in 2013, by applying the life quality assessment tool of the World Health Organization (WHOQOL-BREF). Results: The domain most affected was health satisfaction, which was negative in both antineoplastic administration cycles, while the perception regarding quality of life was considered regular. The highest average domain was social relations; the lowest average was the psychological domain for both cycles. Conclusion: It is important to know the determinants that influence the quality of life of cancer patients, allowing the improvement of multidisciplinary interventions to increase adaptation to the experience of the disease.